Parkinson's Disease Clinical Trial
Official title:
Expiratory Muscle Training in Patients With Parkinson's Disease
Respiratory difficulty is one of the primary factors leading to death in patients with
Idiopathic Parkinson's Disease (IPD). The progressive degeneration of a family of segregated
motor and non-motor circuits in the brain results in motor and non-motor dysfunction.
Breathing and swallowing are well known to be affected in IPD, and attention to these
functions is fitting since most patients eventually experience morbidity and even mortality
as a result of this dysfunction. Patients with IPD typically become sedentary and lose
endurance, maximal fitness levels and overall pulmonary function. Much of the research focus
has been on the motor symptoms of IPD (tremor, rigidity, bradykinesia) yet the pulmonary
complications are perhaps ultimately the most important disability. The inability to
generate adequate respiratory pressure is responsible for reduced cough magnitudes and cough
response times. Cough is critical for the clearance of foreign materials in the airway
helping to reduce infiltration of bacteria and subsequent respiratory infection. With
reduced cough function an increased risk for pulmonary disease due to a reduced ability to
protect the airways occurs. Moreover, the recognized debilitating disruptions to voice and
speech characteristics that limit communication, care taking, employment opportunities and
social interactions are also a result of poor respiratory function. There are a number of
promising outcomes from an expiratory strength-training program. By increasing expiratory
muscle strength and expiratory pressure generation, effective breathing, clearance of the
airway, production of a louder and clearer voice as well as improved swallowing can occur.
These explicit outcomes are predicted based on our experience with the use of an innovative
device-driven, home-based expiratory strength training program focused on the expiratory
muscles of respiration.
The aims of this study are to: 1) Investigate the activity of expiratory muscle strength
training (EMT) in patients with idiopathic Parkinson's disease (IPD), 2) Determine the
effect of increased expiratory force generation on breathing, cough magnitude, speech
production, and swallowing, 3) Determine the effect of increased expiratory force generation
on the patient's perception of speech change, 4) Determine the effect of
Dopamine-replacement therapy (Parkinson's medications) on breathing, coughing, speaking, and
swallowing measures.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Completed |
NCT02939391 -
A Study of KW-6356 in Subjects With Early Parkinson's Disease
|
Phase 2 |